Literature DB >> 19483298

Differential induction of apoptosis of leukemic cells by rhizochalin, two headed sphingolipids from sponge and its derivatives.

Jun-O Jin1, Valeria Shastina, Joo-In Park, Jin-Yeong Han, Tatyana Makarieva, Sergey Fedorov, Valery Rasskazov, Valentin Stonik, Jong-Young Kwak.   

Abstract

Two-headed sphingolipids bear a certain similarity with sphingolipids in the structure and but differing from classical sphingolipids in alpha,omega-position of the basic groups. We analyzed the apoptotic effects of some two-headed sphingolipids including rhizochalin (Rhz) and its derivatives isolated from sponge Rhizochalina incrustata on human leukemia HL-60 cells. Direct addition of Rhz induced apoptosis of HL-60 cells. The aglycon of Rhz, which has no galactosyl residue, showed a stronger ability to induce apoptotic activity than Rhz. Rhz congeners with acetate derivatives only weakly induced apoptosis. The usual mitochondrial membrane permeability changes and the decrease of protein levels of procaspases-8, -9, and -3 correlated with the apoptotic activity of Rhzs. These results suggest that derivatives of two-headed sphingolipids potently induce apoptosis in mammalian cells when administered exogenously and this cell death was dependent on caspase activation pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19483298     DOI: 10.1248/bpb.32.955

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Isorhizochalin: a minor unprecedented bipolar sphingolipid of stereodivergent biogenesis from the Rhizochalina incrustata.

Authors:  Tatyana N Makarieva; Alexander M Zakharenko; Pavel S Dmitrenok; Alla G Guzii; Vladimir A Denisenko; Alexandra S Savina; Doralyn S Dalisay; Tadeusz F Molinski; Valentin A Stonik
Journal:  Lipids       Date:  2009-10-30       Impact factor: 1.880

2.  Ca2+, Mg2+-dependent DNase involvement in apoptotic effects in spermatozoa of sea urchin Strongylocentrotus intermedius induced by two-headed sphingolipid rhizochalin.

Authors:  Juriy T Sibirtsev; Valeria V Shastina; Natalia I Menzorova; Tatyana N Makarieva; Valeriy A Rasskazov
Journal:  Mar Biotechnol (NY)       Date:  2010-10-12       Impact factor: 3.619

Review 3.  Glycosides from marine sponges (Porifera, Demospongiae): structures, taxonomical distribution, biological activities and biological roles.

Authors:  Vladimir I Kalinin; Natalia V Ivanchina; Vladimir B Krasokhin; Tatyana N Makarieva; Valentin A Stonik
Journal:  Mar Drugs       Date:  2012-08-10       Impact factor: 6.085

Review 4.  Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment.

Authors:  Magbubah Essack; Vladimir B Bajic; John A C Archer
Journal:  Mar Drugs       Date:  2011-09-20       Impact factor: 6.085

5.  Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer.

Authors:  Sergey A Dyshlovoy; Katharina Otte; Kseniya M Tabakmakher; Jessica Hauschild; Tatyana N Makarieva; Larisa K Shubina; Sergey N Fedorov; Carsten Bokemeyer; Valentin A Stonik; Gunhild von Amsberg
Journal:  Oncotarget       Date:  2018-03-30

Review 6.  Secondary Metabolites from Marine Sponges of the Genus Oceanapia: Chemistry and Biological Activities.

Authors:  Meng-Juan Xu; Lin-Jing Zhong; Jun-Kun Chen; Qing Bu; Lin-Fu Liang
Journal:  Mar Drugs       Date:  2022-02-16       Impact factor: 5.118

Review 7.  Marine Sponge Natural Products with Anticancer Potential: An Updated Review.

Authors:  Cinzia Calcabrini; Elena Catanzaro; Anupam Bishayee; Eleonora Turrini; Carmela Fimognari
Journal:  Mar Drugs       Date:  2017-10-13       Impact factor: 5.118

Review 8.  A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011.

Authors:  Wamtinga Richard Sawadogo; Marc Schumacher; Marie-Hélène Teiten; Claudia Cerella; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2013-03-25       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.